Velan Capital Investment Management’s Alimera Sciences ALIM Stock Holding History

Velan Capital Investment Management’s Portfolio ALIM Stock Details ALIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-13,608,533	Closed	-$75.7M	–	22
2024 Q2	$75.7M	Hold	13,608,533	–	–	43.35%	1
2024 Q1	$53.1M	Hold	13,608,533	–	–	24.1%	1
2023 Q4	$58.8M	Hold	13,608,533	–	–	34.31%	1
2023 Q3	$42.2M	Buy	13,608,533 +11,948,879	+720%	+$39.5M	34.02%	1
2023 Q2	$4.85M	Buy	1,659,654 +1,401,901	+544%	+$3.22M	4.5%	8
2023 Q1	$541K	Hold	257,753	–	–	0.46%	25
2022 Q4	$699K	Buy	257,753 +30,151	+13%	+$128K	0.62%	24
2022 Q3	$1.16M	Buy	227,602 +40,601	+22%	+$247K	1.15%	15
2022 Q2	$1.02M	Buy	+187,001	New	+$1.03M	1.04%	17

Velan Capital Investment Management's ALIM Position: Q3 2024 in Review

Velan Capital Investment Management sold out of Alimera Sciences (ALIM) in Q3 2024, closing a stake of 13,608,533 shares — an estimated $75.7M sold.

Velan Capital Investment Management first reported a position in ALIM in Q2 2022 and held it in 9 quarters. The position peaked at $75.7M in Q2 2024. 0 funds tracked by Wall St. Rank hold ALIM as of Q3 2024.

Velan Capital Investment Management reported no remaining Alimera Sciences position as of Q3 2024 after selling out during the quarter.
Velan Capital Investment Management sold 13,608,533 Alimera Sciences shares in Q3 2024, an estimated $75.7M.
Velan Capital Investment Management first reported a position in Alimera Sciences in Q2 2022 and held it in 9 quarters.
Velan Capital Investment Management's Alimera Sciences position peaked at $75.7M in Q2 2024.
0 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2024.

Based on Velan Capital Investment Management's 13F filing for Q3 2024, filed 14 Nov 2024.